Cellink Competitors and Similar CompaniesClear all
Cellink's competitors and similar companies include inviCRO, Autolus, Centogene and Apeel Sciences.
 Cellink CELLINK is a company that develops bioprinting technologies that allow researchers to 3D print human organs and tissue models of pharmaceutical and cosmetic products. |  Autolus Autolus Therapeutics is a private biopharmaceutical company, focused on the development and commercialization of engineered T-cell immunotherapy products. |  Centogene Centogene is a biotechnology company that provides services in the field of genetic diagnostics for rare hereditary diseases. |  Apeel Sciences Apeel Sciences (also known as Apeel Technology) is a company focusing on food processing and waste management. | ||
Founding Date | Founding Date 2016 | Founding Date 2008 | Founding Date 2014 | Founding Date 2005 | Founding Date 2012 |
Type | Type Subsidiary | Type Private | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Göteborg, SE HQ Dardilly, FR Kyoto, JP Göteborg, SE Brighton, GB Blacksburg, US Boston, US | Locations Boston, US HQ London, GB Doylestown, US New Haven, US New Haven, US | Locations London, GB HQ London, GB | Locations Rostock, DE HQ Wien, AT Berlin, DE Frankfurt Am Main, DE Hamburg, DE Greater Noida, IN Dubai, AE see more | Locations Goleta, US HQ |
Employees | Employees 983% decrease | Employees 2008% decrease | Employees 463 | Employees 80823% increase | Employees 261 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 1.2 b | Valuation ($) 9.4 m | Valuation ($) 1 b |
Financial | |||||
Revenue (est.) | Revenue (est.) kr74.2m (FY, 2021) | Revenue (est.) N/A | Revenue (est.) $1.7m (FY, 2023) | Revenue (est.) €48.5m (FY, 2023) | Revenue (est.) N/A |
Cost of goods | Cost of goods kr40.2m (FY, 2021) | Cost of goods N/A | Cost of goods N/A | Cost of goods €29.1m (FY, 2023) | Cost of goods N/A |
Gross profit | Gross profit kr34.1m (FY, 2021) | Gross profit N/A | Gross profit $1.7m (FY, 2023) | Gross profit €23.7m (FY, 2023) | Gross profit N/A |
Net income | Net income (kr27.4m) (FY, 2021) | Net income N/A | Net income ($208.4m) (FY, 2023) | Net income (€35.5m) (FY, 2023) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 45.8m (almost 9 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 30m (about 4 years ago) |
Total funding raised | Total funding raised $ 4.1m | Total funding raised $ 45.8m | Total funding raised $ 281.7m | Total funding raised $ 29.6m | Total funding raised $ 384.3m |
For sources of this data, please see the company profile
View Company Profiles
inviCRO
HQ
Boston, US
Employees
200↓ 8% decrease
inviCRO provides a suite of services and software for medical imaging analysis.
View companyAutolus
HQ
London, GB
Employees
463
Autolus Therapeutics is a private biopharmaceutical company, focused on the development and commercialization of engineered T-cell immunotherapy products.
View companyCentogene
HQ
Rostock, DE
Employees
808↑ 23% increase
Centogene is a biotechnology company that provides services in the field of genetic diagnostics for rare hereditary diseases.
View companyApeel Sciences
HQ
Goleta, US
Employees
261
Apeel Sciences (also known as Apeel Technology) is a company focusing on food processing and waste management.
View company